|Articles|April 1, 2006

Pharmacy Times

  • Volume 0
  • 0

Long-term LNG/EE Use Does Not Hinder Future Ovulation

Author(s)Susan Farley

The results of a single-center, singletreatment,open-label study show thatthe long-term use of Wyeth's oral levonorgestrel(LNG) 90 μg/ethinyl estradiol(EE) 20 μg had no ill effects on theresumption of ovulation after stoppingtreatment. The study involved healthywomen aged 18 to 35 years who participatedfor ~8 months, including up to 84days of posttreatment observation forthe return of ovulation. Ovarian activitywas assessed by measuring progesteroneand other hormone levels 3 timesper week during treatment. Of the 58participants who received the treatment,37 completed the study successfully andshowed no signs of ovulation duringtreatment. After treatment was ended,all these patients resumed ovulationwithin 31 days; 7 resumed between days8 and 14. The study results were presentedat the Annual Meeting of theAmerican Society for ReproductiveMedicine on October 17, 2005.

Ms. Farley is a freelance medicalwriter based in Wakefield, RI.

Articles in this issue

over 19 years ago

Pharmacists—Cops or Not? (Part 2)

over 19 years ago

canyouREADtheseRxs?

over 19 years ago

compoundingHOTLINE

over 19 years ago

NSAIDs and Antihypertensive Agents

over 19 years ago

FDA Approves New Constipation Drug

over 19 years ago

Angina Drug Approved

over 19 years ago

Compounding for Vaginal Conditions

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME